Zofia E. Dziewanowska
Keine laufenden Positionen mehr
Profil
Zofia E.
Dziewanowska held several high-ranking positions in the pharmaceutical industry, including Vice President of Clinical Research at Ligand Pharmaceuticals and Senior Vice President of Global Clinical Research and Development at Cypros Pharmaceutical Corp.
She also served as Vice Chairman of the Medical Section Steering Committee at the Pharmaceutical Research & Manufacturers of America and Chairman of the Education Committee at the American Academy of Pharmaceutical Physicians.
Prior to her industry career, she earned doctorates from Warsaw University of Technology, the University of Warsaw, and the Polish Academy of Sciences.
Ehemalige bekannte Positionen von Zofia E. Dziewanowska
Unternehmen | Position | Ende |
---|---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Cypros Pharmaceutical Corp. | Technik-/Wissenschafts-/F&E-Leiter | 21.09.2007 |
MERCK & CO., INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1994 |
American Academy of Pharmaceutical Physicians | Corporate Officer/Principal | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Corporate Officer/Principal | - |
Ausbildung von Zofia E. Dziewanowska
Warsaw University of Technology | Doctorate Degree |
University of Warsaw | Doctorate Degree |
Polish Academy of Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Cypros Pharmaceutical Corp. | Health Technology |
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
American Academy of Pharmaceutical Physicians |